In triple-negative breast cancer (TNBC), the knockdown of FZD8 results in enhanced apoptosis with down-regulated β-catenin and survivin expression, and sensitizes the TNBC cells to chemotherapy, such as cisplatin plus TRAIL [33]. Here, TNFSF10 is linked to triple-negative breast carcinoma.